Brief: Mesoblast Partners With Blood And Marrow Transplant Clinical Trials Network
Nov 22 (Reuters) - Mesoblast Ltd MSB.AX :
* PARTNERS WITH BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS
NETWORK (BMT CTN)
* AGREEMENT TO DEVELOP A PIVOTAL TRIAL OF CO'S LEAD PRODUCT
CANDIDATE RYONCIL
Source text for Eikon: ID:nASX8wYnYX
Further company coverage: MSB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mesoblast
See all newsBrief: Mesoblast William Burns To Retire From Board At 2026 AGM
Brief: Mesoblast Says Q1 Net Revenues Up 44%
Australia's Mesoblast hits one-month high on upbeat quarterly update
Australia's Mesoblast drops as Bell Potter cuts target price after key drug misses sales view
Brief: Mesoblast Says FDA Approves New Potency Assay For Commercial Ryoncil